Genzyme Corp - Strategic SWOT Analysis Review

Genzyme Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy its summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities A list of key manufacturing facilities of the company.

Highlights

Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab for multiple myeloma; and Fitisuran for Hemophilia, among others. The company primarily focuses on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. Genzyme also develops products for the treatment of cardiovascular diseases, neurodegenerative diseases and other areas. It operates a research and development lab and manufacturing plants in the US, Belgium and Ireland. The company has presence in the Americas, Europe, Asia-Pacific, Middle East and Africa. Genzyme is headquartered in Massachusetts, the US.

Genzyme Corp Key Recent Developments

Jan 31,2018: Sanofi Genzyme Highlights rare disease data at WORLDSymposium 2018
Mar 22,2017: Sanofi Genzyme Extends Its Multiple Myeloma Journey Partners Program To Cities Nationwide To Help Improve Patient Outcomes Through Peer-to-Peer Education
Feb 09,2017: Sanofi Genzyme Commitment to Patients with Rare Diseases Highlighted at WORLDSymposium 2017

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with its detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.



List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Genzyme Corp - Key Facts 5
Genzyme Corp - Key Employees 6
Genzyme Corp - Major Products and Services 7
Genzyme Corp - History 8
Genzyme Corp - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 15
Section 2 Company Analysis 16
Company Overview 16
Genzyme Corp - Business Description 17
Genzyme Corp - Corporate Strategy 18
Genzyme Corp - SWOT Analysis 19
SWOT Analysis - Overview 19
Genzyme Corp - Strengths 19
Genzyme Corp - Weaknesses 20
Genzyme Corp - Opportunities 21
Genzyme Corp - Threats 22
Genzyme Corp - Key Competitors 23
Section 3 Companys Lifesciences Financial Deals and Alliances 24
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25
Genzyme Corp, Recent Deals Summary 26
Section 4 Companys Recent Developments 27
Jan 31, 2018: Sanofi Genzyme highlights rare disease data at WORLDSymposium 2018 27
Mar 22, 2017: Sanofi Genzyme Extends Its Multiple Myeloma Journey Partners Program To Cities Nationwide To Help Improve Patient Outcomes Through Peer-to-Peer Education 28
Feb 09, 2017: Sanofi Genzyme Commitment to Patients with Rare Diseases Highlighted at WORLDSymposium 2017 29
Section 5 Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables


Genzyme Corp, Key Facts 5
Genzyme Corp, Key Employees 6
Genzyme Corp, Major Products and Services 7
Genzyme Corp, History 8
Genzyme Corp, Other Locations 13
Genzyme Corp, Subsidiaries 13
Genzyme Corp, Joint Venture 15
Genzyme Corp, Key Competitors 23
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25
Genzyme Corp, Recent Deals Summary 26

List Of Figures


Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 25

Genzyme Corp - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment

USD 250 View Report

Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report

Sanofi Genzyme - Strategy, SWOT and Corporate Finance ReportSanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the

USD 175 View Report

VWR Corp - Medical Equipment - Deals and Alliances Profile

VWR Corp (VWR), a subsidiary of Avantor Performance Materials Inc, is a medical equipment company that distributes laboratory products, and provides services and solutions. The company offers product such chemicals,

USD 250 View Report

Lucigen Corp - Product Pipeline Analysis, 2018 Update

Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The companys products comprise competent cells, nextgen seq, enzymes,

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available